IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarepta Therapeutics, Inc.

CIK: 0000873303 | Cambridge, MA

Q1 2026 vs Q2 2026 ComparisonProfile

Filing History

QuarterForm TypeHoldingsValueFiledSEC
Q2 2026
13F-HR1$02026-08-14SEC ↗
Q1 2026
13F-HR1$02026-05-13SEC ↗
Q4 2025
13F-HR1$02026-02-13SEC ↗